Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.01.08.631974

Robustness of Selection and Timing Inference under Model Variation in Population Genetics

Abstract

1In population genetics, accurately inferring the selection coefficient and the time of onset of advantageous mutations from genetic data is fundamental for understanding evolutionary processes. Here, we investigate how mismatches between the true evolutionary process and the inference model--specifically in the reproductive variance ({sigma}2) and the number of generations (L)--affect the posterior distributions of the selection coefficient and the time of onset. Using the Kolmogorov forward and backward equations, we model the stochastic dynamics of gene frequencies under selection and drift. We show that while the posterior distribution of the selection coefficient remains unaffected by changes in{sigma} 2 and L, this invariance does not apply to the time of onset. By framing the problem as a first passage time issue, we derive explicit expressions for the offsets in the posterior mean and variance of the time of onset that result from incorrect assumptions about{sigma} 2 and L. Our analysis reveals that these offsets are related to the mean and variance of the first passage time required for the allele frequency to reach a certain threshold, starting from an initial frequency determined by the model parameters. Under the assumption of a uniform prior for the time of onset, we find that the offset in the inferred mean is given by the difference in the effective generation duration ({Delta} = 1/{sigma}2) between the true process and the inference model. We validate our theoretical findings through simulations, demonstrating that the empirical offsets closely match our predictions. Furthermore, we generalize our results to accommodate non-uniform prior distributions, such as exponential priors, and provide numerical methods for calculating offsets under arbitrary priors. Stochastic fluctuations due to genetic drift, which are influenced by the reproductive variance and generational structure, can introduce significant biases in the posterior distribution of time of onset of advantageous mutations. By quantifying these biases, our framework enables more accurate adjustments to inferences drawn from genetic data, thereby enhancing our understanding of evolutionary dynamics and improving the reliability of population genetic analyses.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Escabi, J., Hormoz, S.. 2025-01-10. Robustness of Selection and Timing Inference under Model Variation in Population Genetics. https://doi.org/10.1101/2025.01.08.631974

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗